⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
prnewswire.com
NVS
Le CAS annonce une collaboration avec Novartis pour faire progresser l'informatique des réactions adaptée à l'IA
prnewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Bronstein, Gewirtz & Grossman, LLC Encourages Novartis AG (NVS) Shareholders to Inquire about Securities Investigation
accessnewswire.com
NVS
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
Global Cyclic Peptide Library Market Outlook and Forecast, 2026-2032 - AI-Enabled Discovery Fuels 16.32% CAGR Toward USD 9.86 Billion as PeptiDream, Bicycle Therapeutics, Pfizer and Roche Advance Competition
globenewswire.com
PFE
AMGN
AZN
EVTC
MRK
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Novartis AG (NVS) And Encourages Shareholders to Connect
accessnewswire.com
NVS
Breast Cancer Continues to Impact Communities; Austin Rallies Together to Take Action at Susan G. Komen® Austin MORE THAN PINK Walk
businesswire.com
DELL
BAC
NTRA
LLY
NVS